We invite you to take part in a webinar on July 17 with Prof. Dr. Lesinski-Schiedat. Make sure not to miss this opportunity!
It will be the last PORA Webinar before the summer break and with our invited speaker Prof. Dr. Anke Lesinski-Schiedat we have one of the most experienced ENT experts in the field of CI.
She is senior physician at the Medical Highschool Hannover (MHH) — internationally renowned for having the world’s largest cochlear implant programme. This was established by Prof. Dr. Ernst Lehnhardt, who provided 4 adults with a multichannel CI – first in Europe! In 1984, in 1987 the first child post-meningitis and in 1988 the first deaf born child at the age of 1 ½ years. He also established the first CI rehabilitation Center in 1991.
When he retired in 1983,Prof. Thomas Lenarz became head of the ENT clinic.
Prof. Lesinski-Schiedat has 25 years of experience and a broad and profound knowledge which she will share with us.
Dr.Dr.h.c.Monika Lehnhardt-Goriany
Eva Bültmann and Anke Lesinski-Schiedat
MRI in Cochlear Implant Recipients: Correlation between Receiver Position and Artifact
Ann Otolaryngol Rhinol 8(4): 1278 (2021)
F. Matin, S. Haumann, W. Roßberg, D. Mitovska, T. Lenarz & A. Lesinski-Schiedat
Monitoring of the auditory pathway maturation after early intervention during the first year of life in infants with sensorineural hearing loss
European Archives of Oto-Rhino-Laryngology volume 278, pages 4187–4197 (2021)
Recording of webinar «Challenges and results in pediatric CI therapy»
The Department of Otorhinolaryngology at MHH is internationally renowned for having the world’s largest cochlear implant programme, aimed at both hearing-impaired and deaf
patients. One of our priority areas, therefore, is provision of hearing systems – from the development of the devices themselves to lifelong support for our patients. Together, the
German Hearing Center Hannover and the scientific laboratories form the joint platform for these activities.
Other priorities include the early detection of hearing loss in children, the diagnosis and treatment of inner-ear conditions including tinnitus, the full range of middle-ear surgical
procedures and provision of partially implantable hearing systems, skull base surgery including treatment of acoustic neurinoma, tumour surgery using modern laser surgical and endoscopic
techniques, as well as the treatment of chronic inflammation of the nose and sinuses, covering allergology, environmental medicine and plastic/reconstructive techniques.
Long history:
In 1984 Prof. Ernst Lehnhardt provided 4 adults with a multichannel CI – first in Europe! in 1987 the first child post-meningitis and in 1988 the first deaf born child at the age of 1 1⁄2 years.
At that time a curageous decision.
He estblished the first CI rehabilitation Center in 1991.
He retired in 1983. Prof. Thomas Lenarz became head of the ENT clinic.
Deutsches Hörzentrum —Two Million EURO for research at MHH. April 2022
Professor Dr. Waldo Nogueira Vazquez, head of the hearing prosthetics research group at the Department of Otorhinolaryngology at Hanover Medical School (MHH), wants to find out how
residual hearing can be assessed and preserved more precisely, how the electrical stimulation by the CI interacts with the acoustic signal conduction and how a new type of hearing prosthesis
can be developed from these findings. For his project «READIHEAR», the scientist has now received the «ERC Consolidator Grant» from the European Research Council (ERC), one of the
European Union’s highest scientific grants for excellence. It will be funded with a total of around two million euros over five years.
Identifying and preserving residual hearing
If residual hearing is present, hearing aids and CI can be used simultaneously in the same ear. With this concept of combined electric-acoustic stimulation (EAS), the hearing aid amplifies the
low frequencies acoustically, while the CI stimulates the middle and high frequency ranges electrically. The inner ear processes the acoustic and electrical stimuli simultaneously. The disadvantage: When inserting the CI, the very sensitive structures of the cochlea and thus also the residual hearing can be damaged. The scientist now wants to develop objective diagnostic
instruments that determine how much hearing potential is present at all, especially in newborns, and that simultaneously monitor low-frequency hearing during insertion.